Research Article

miR-141-3p is Poorly Expressed in Polycystic Ovary Syndrome and Correlates with Glucose and Lipid Metabolism

Table 3

Correlation analysis between serum miR-141-3p expression and clinical parameters in PCOS patients.

ParametersPCOS-nonobese (N = 57)PCOS-obese (N = 43)
Pearson r valuePearson r value

Age (years)/0.974/0.557
BMI (kg/m2)/0.972/0.557
WHR/0.279−0.4270.004
TG (mmol/L)−0.3260.013−0.3380.026
TC (mmol/L)−0.2690.043−0.4320.004
LDL-C (mmol/L)/0.304/0.233
HDL-C (mmol/L)/0.0910.4340.004
FBG (mmol/L)/0.306−0.4210.005
FINS (mIU/L)−0.47<0.001−0.656<0.001
HbAlc (%)−0.4130.001−0.55<0.001
HOMA-β−0.538<0.001−0.584<0.001
HOMA-IR−0.519<0.001−0.4570.002

Note. BMI, body mass index; WHR, waist-to-hip ratio; TG, triglyceride; TC, total cholesterol; LDL-C, low density lipoprotein cholesterin; HDL-C, high density lipoprotein cholesterin; FBG, fasting blood glucose; FINS, fasting insulin; HbAlc, glycosylated hemoglobin; HOMA-β, homeostasis model assessment of beta cell function index; HOMA-IR, homeostasis model assessment of insulin resistance.